Medtronic plc

MDT · Large cap · 2 articles

Financial highlights

Metric	FY 04/24/26	FY 04/25/25	FY 04/26/24	FY 04/28/23	FY 04/29/22
Income Statement
Revenue	$36.4B	$33.5B	$32.4B	$31.2B	$31.7B
Cost of revenue	$12.7B	$11.6B	$11.2B	$10.7B	$10.1B
Selling, general & administrative	$11.8B	$10.8B	$10.7B	$10.4B	$10.3B
Research and development	$2.9B	$2.7B	$2.7B	$2.7B	$2.7B
Operating income	$6.5B	$6.0B	$5.1B	$5.5B	$5.8B
Interest expense	$715.0M	$729.0M	$719.0M	$636.0M	$553.0M
Pretax income	$6.1B	$5.6B	$4.8B	$5.4B	$5.5B
Income tax expense	$1.3B	$936.0M	$1.1B	$1.6B	$456.0M
Net income	$4.8B	$4.7B	$3.7B	$3.8B	$5.0B
Balance Sheet
Cash and equivalents	$1.9B	$2.2B	$1.3B	$1.5B	$3.7B
Current assets	$24.8B	$23.8B	$21.9B	$21.7B	$23.1B
Total assets	$93.0B	$91.7B	$90.0B	$90.9B	$91.0B
Current liabilities	$11.7B	$12.9B	$10.8B	$9.1B	$12.4B
Total liabilities	$43.0B	$43.4B	$39.6B	$39.3B	$38.3B
Total debt	$28.1B	$28.7B	$25.2B	$24.6B	$24.3B
Stockholders' equity	$49.5B	$48.0B	$50.2B	$51.5B	$52.6B
Cash Flow Statement
Cash from operations	$7.3B	$7.0B	$6.8B	$6.0B	$7.3B
Depreciation and amortization	$3.0B	$2.9B	$2.6B	$2.7B	$2.7B
Stock-based compensation	$457.0M	$429.0M	$393.0M	$355.0M	$359.0M
Capital expenditure	$1.9B	$1.9B	$1.6B	$1.5B	$1.4B
Free cash flow	$5.4B	$5.2B	$5.2B	$4.6B	$6.0B
Dividends paid	$3.6B	$3.6B	$3.7B	$3.6B	$3.4B
Share repurchases	$1.0B	$3.2B	$2.1B	$645.0M	$2.5B
Impairments	$0	$0	$371.0M	$0	$515.0M

Shares outstanding 1.3B · Free float 9.7%

Annual filing data through FY ended April 24, 2026; float as of July 4, 2026.